Open AccessBeta-blockers in hypertension treatment - did the time of farewell come?
Author(s) -
Alexandra Konradi
Publication year - 2006
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2006-12-3-212-215
Subject(s) - atenolol , betaxolol , beta (programming language) , medicine , drug , pharmacology , adverse effect , blood pressure , timolol , surgery , computer science , intraocular pressure , programming language
During the last two years the issue of use of beta-blockers in first line hypertension therapy is debated. Besides, evidence for refuse from wide of these agents is obtained from trials, testing relatively old agents such as atenolol with a number of negative metabolic effects. At the same time, newer representatives of beta-blockers with high selectivity, for example betaxolol do not. produce such adverse effects. This can indicate that the data obtained on atenolol cannot be extrapolated on the whole drug class.